Experience
Medtronic Vascular Inc. v. Abbott Vascular, Inc.
Medtronic Vascular Inc.
Abbott Vascular, Inc.
Represented Abbott in multiple patent litigations relating to its market-leading Vision™ bare-metal stent and Xience™ drug-eluting stent. Case settled on the Friday before jury selection, with Medtronic paying client Abbott $400 million to settle all global patent disputes.
Medtronic Vascular Inc. v. Abbott Vascular, Inc., 4:06-cv-01066, N.D. Cal., Judges Chen, Hamilton
